NCT00088868
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +51 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,043 public trials
2,030 recruiting studies
Lymphoproliferative Disorders trial results
NCT00030108
- Conditions
- Adnexal Diseases, Astrocytoma, Bone Marrow Diseases, +92 more
- Locations
-
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT01553357
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- IRCCS - CROB Ethic Committee Rionero in Vulture, Pz, Italy
NCT00211276
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- Pacific Coast Hematology/Oncology Fountain Valley, California, United States
- University of California, Los Angeles Los Angeles, California, United States
- Emory University Atlanta, Georgia, United States
NCT00945828
- Conditions
- Acute Lymphoblastic Leukemia, Central Nervous System Neoplasms, Central Nervous System Tumors, +15 more
- Locations
-
- Mailman Center for Child Development University of Miami Miller School of Medicine Miami, Florida, United States
NCT00064311
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
NCT00080925
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +65 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Completed
Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma
NCT00589381
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
- Locations
-
- Childrens Hospital Los Angeles Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00499759
- Conditions
- Behavior, Behavioral Symptoms, Congenital Abnormalities, +21 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States